You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Drug Sales Trends for ESOMEPRA MAG


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for ESOMEPRA MAG (2021)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $17,521,384
INSIDE ANOTHER STORE $107,339,949
[disabled in preview] $287,113,414
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 289,308
INSIDE ANOTHER STORE 617,806
[disabled in preview] 2,631,398
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $18,046,517
MEDICARE $206,663,147
[disabled in preview] $191,731,619
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ESOMEPRA MAG
Drug Units Sold Trends for ESOMEPRA MAG

Annual Sales Revenues and Units Sold for ESOMEPRA MAG

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ESOMEPRA MAG ⤷  Try a Trial ⤷  Try a Trial 2021
ESOMEPRA MAG ⤷  Try a Trial ⤷  Try a Trial 2020
ESOMEPRA MAG ⤷  Try a Trial ⤷  Try a Trial 2019
ESOMEPRA MAG ⤷  Try a Trial ⤷  Try a Trial 2018
ESOMEPRA MAG ⤷  Try a Trial ⤷  Try a Trial 2017
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.